Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
JACC Cardiovasc Imaging ; 3(1): 101-10, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20129539

ABSTRACT

Sudden cardiac death remains the leading cause of death in the U.S. A left ventricular ejection fraction (LVEF)<30% to 35% identifies a population of patients at increased risk for sudden cardiac death. Once identified, an implantable cardioverter-defibrillator (ICD) is effective in reducing the occurrence of sudden cardiac death. Yet in a substantial proportion of patients who receive an ICD based on reduced LVEF, the device never delivers therapy. Furthermore, the majority of patients who die suddenly do not qualify for ICD placement under current LVEF-based criteria in the guidelines. This review considers the potential role of cardiac imaging in improving the selection of patients most likely to benefit from an ICD. The presence of myocardial scar and/or unrevascularized myocardial ischemia provides an important substrate for the occurrence of potentially fatal ventricular arrhythmias. The presence of clinical heart failure further increases the risk of ventricular arrhythmia. The sympathetic nervous system provides an important trigger for major arrhythmic events, both through global overactivity and through regional heterogeneity of sympathetic activity. A mismatch of myocardial perfusion and innervation may pose a particularly great risk. Imaging modalities provide unique opportunities to investigate the anatomic and pathophysiologic substrates, as well as the triggering effects of cardiac sympathetic innervation. Combining imaging and electrophysiologic modalities offers promise for improved accuracy in future selection of patients with heart failure for ICD placement.


Subject(s)
Arrhythmias, Cardiac/therapy , Death, Sudden, Cardiac/prevention & control , Defibrillators, Implantable , Diagnostic Imaging , Electric Countershock/instrumentation , Heart Failure/diagnosis , Heart Failure/therapy , Patient Selection , Arrhythmias, Cardiac/etiology , Arrhythmias, Cardiac/physiopathology , Death, Sudden, Cardiac/etiology , Diagnostic Imaging/methods , Heart/innervation , Heart Failure/complications , Heart Failure/physiopathology , Humans , Myocardial Ischemia/complications , Myocardial Ischemia/pathology , Myocardial Ischemia/physiopathology , Myocardium/pathology , Practice Guidelines as Topic , Predictive Value of Tests , Risk Assessment , Risk Factors , Sympathetic Nervous System/physiopathology , Time Factors , Treatment Outcome
2.
Am J Physiol Heart Circ Physiol ; 297(1): H117-24, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19429829

ABSTRACT

Cardiac L-type voltage-dependent Ca(2+) channels are heteromultimeric polypeptide complexes of alpha(1)-, alpha(2)/delta-, and beta-subunits. The alpha(2)/delta-1-subunit possesses a stereoselective, high-affinity binding site for gabapentin, widely used to treat epilepsy and postherpetic neuralgic pain as well as sleep disorders. Mutations in alpha(2)/delta-subunits of voltage-dependent Ca(2+) channels have been associated with different diseases, including epilepsy. Multiple heterologous coexpression systems have been used to study the effects of the deletion of the alpha(2)/delta-1-subunit, but attempts at a conventional knockout animal model have been ineffective. We report the development of a viable conventional knockout mouse using a construct targeting exon 2 of alpha(2)/delta-1. While the deletion of the subunit is not lethal, these animals lack high-affinity gabapentin binding sites and demonstrate a significantly decreased basal myocardial contractility and relaxation and a decreased L-type Ca(2+) current peak current amplitude. This is a novel model for studying the function of the alpha(2)/delta-1-subunit and will be of importance in the development of new pharmacological therapies.


Subject(s)
Calcium Channels, L-Type/physiology , Calcium Channels/physiology , Amines/metabolism , Animals , Binding Sites/drug effects , Binding Sites/genetics , Blotting, Western , Calcium Channels/drug effects , Calcium Channels/genetics , Calcium Channels, L-Type/drug effects , Calcium Channels, L-Type/genetics , Cyclohexanecarboxylic Acids/metabolism , Electrophysiology , Exons/genetics , Gabapentin , Genotype , Heart/drug effects , Mice , Mice, Knockout , Muscle, Skeletal/cytology , Muscle, Skeletal/metabolism , Myocardial Contraction/drug effects , Myocardial Contraction/genetics , Myocytes, Cardiac/drug effects , Patch-Clamp Techniques , Reverse Transcriptase Polymerase Chain Reaction , gamma-Aminobutyric Acid/metabolism
3.
J Am Coll Cardiol ; 41(9): 1611-22, 2003 May 07.
Article in English | MEDLINE | ID: mdl-12742305

ABSTRACT

OBJECTIVES: This study was designed to identify possible electrical remodeling (ER) in transgenic (Tg) mice with over-expressed L-type Ca(2+) channels. Transient outward K(+) current (I(to)) and action potential duration (APD) were studied in 2-, 4-, 8-, and 9- to 12-month-old mice to determine linkage to ventricular remodeling (VR), ER, and heart failure (HF). BACKGROUND: Prolongation of APD and reduction in current density of I(to) are thought to be hallmarks of VR and HF. Mechanisms are not understood. METHODS: Patch-clamp, perfused hearts, echocardiography, and Western blots were employed using 2-, 4-, 8-, and 9- to 12-month-old Tg mice. RESULTS: Transgenic mice developed slow VR statistically manifesting at four months and continuing through death at 12 to 14 months, despite a slight up-regulation of I(to). A slight decrease or no change in APD was observed up to eight months; however, at 9 to 12 months, a small increase in APD was detected. Early afterdepolarizations were observed after application of 4-aminopyridine in Tg mice. No change was detected in protein of Kv4.3 and Kv4.2 up to eight months. At 9 to 12 months, Tg mice showed a slight decrease (41.4 +/- 6.9%, p < 0.05) in Kv4.2, consistent with a decrease in I(to). Surprisingly, Kv1.4 (the "fetal" K(+)-channel form) was up-regulated, and restitution of I(to) was slowed. Echocardiography revealed cardiac enlargement with impaired chamber function in hearts that were taken from the older animals. CONCLUSIONS: Contrary to accepted dogma, APD and I(to) in a mouse model of hypertrophy and HF are not hallmarks of pathophysiology. We suggest that [Ca(2+)](i) (i.e., [Ca(2+)] concentration) is the primary factor in triggering cardiac enlargement and arrhythmogenesis.


Subject(s)
Action Potentials/physiology , Calcium Channels, L-Type/physiology , Calcium Signaling/physiology , Cardiomegaly/physiopathology , Heart Failure/physiopathology , Potassium Channels, Voltage-Gated/physiology , Ventricular Remodeling/physiology , Animals , Cardiomegaly/complications , Cardiomegaly/diagnostic imaging , Disease Models, Animal , Echocardiography , Electrophysiology , Heart Failure/diagnostic imaging , Heart Failure/etiology , In Vitro Techniques , Mice , Mice, Transgenic , Risk Factors , Time Factors
4.
Biochem Biophys Res Commun ; 293(5): 1405-11, 2002 May 24.
Article in English | MEDLINE | ID: mdl-12054671

ABSTRACT

The beta subunit of the L-type voltage-dependent calcium channel modifies the properties of the channel complex by both allosteric modulation of the alpha1 subunit function and by chaperoning the translocation of the alpha1 subunit to the plasma membrane. The goal of this study was to investigate the functional effect of changing the in vivo stoichiometry between the alpha1 and beta subunits by creating a dominant negative expression system in a transgenic mouse model. The high affinity beta subunit-binding domain of the alpha1 subunit was overexpressed in a cardiac-specific manner to act as a beta subunit trap. We found that the predominant beta isoform was located primarily in the membrane bound fraction of heart protein, whereas the beta1 and beta3 were mostly cytosolic. There was a significant diminution of the amount of beta2 in the membrane fraction of the transgenic animals, resulting in a decrease in contractility of the heart and a decrease in L-type calcium current density in the myocyte. However, there were no distinguishable differences in beta1 and beta3 protein expression levels in the membrane bound fraction between transgenic and non-transgenic animals. Since the beta1 and beta3 isoforms only make up a small portion of the total beta subunit in the heart, slight changes in this fraction are not detectable using Western analysis. In contrast, beta1 and beta3 in skeletal muscle and brain, the predominant isoforms in these tissues, respectively, are membrane bound.


Subject(s)
Calcium Channels, L-Type/chemistry , Calcium Channels, L-Type/metabolism , Alternative Splicing , Animals , Blotting, Northern , Blotting, Southern , Blotting, Western , Cell Membrane/metabolism , Cytosol/metabolism , Electrophysiology , Genes, Dominant , Mice , Mice, Transgenic , Myocardium/metabolism , Protein Isoforms , Protein Structure, Tertiary , Tissue Distribution
5.
Circ Res ; 90(2): 174-81, 2002 Feb 08.
Article in English | MEDLINE | ID: mdl-11834710

ABSTRACT

Voltage-gated L-type Ca(2+) channels (LCCs) provide Ca(2+) ingress into cardiac myocytes and play a key role in intracellular Ca(2+) homeostasis and excitation-contraction coupling. We investigated the effects of a constitutive increase of LCC density on Ca(2+) signaling in ventricular myocytes from 4-month-old transgenic (Tg) mice overexpressing the alpha(1) subunit of LCC in the heart. At this age, cells were somewhat hypertrophic as reflected by a 20% increase in cell capacitance relative to those from nontransgenic (Ntg) littermates. Whole cell I(Ca) density in Tg myocytes was elevated by 48% at 0 mV compared with the Ntg group. Single-channel analysis detected an increase in LCC density with similar conductance and gating properties. Although the overexpressed LCCs triggered an augmented SR Ca(2+) release, the "gain" function of EC coupling was uncompromised, and SR Ca(2+) content, diastolic cytosolic Ca(2+), and unitary properties of Ca(2+) sparks were unchanged. Importantly, the enhanced I(Ca) entry and SR Ca(2+) release were associated with an upregulation of the Na(+)-Ca(2+) exchange activity (indexed by the half decay time of caffeine-elicited Ca(2+) transient) by 27% and SR Ca(2+) recycling by approximately 35%. Western analysis detected a 53% increase in the Na(+)-Ca(2+) exchanger expression but no change in the abundance of ryanodine receptor (RyR), SERCA2, and phospholamban. Analysis of I(Ca) kinetics suggested that SR Ca(2+) release-dependent inactivation of LCCs remains intact in Tg cells. Thus, in spite of the modest cardiac hypertrophy, the overexpressed LCCs form functional coupling with RyRs, preserving both orthograde and retrograde Ca(2+) signaling between LCCs and RyRs. These results also suggest that a modest but sustained increase in Ca(2+) influx triggers a coordinated remodeling of Ca(2+) handling to maintain Ca(2+) homeostasis.


Subject(s)
Calcium Channels, L-Type/biosynthesis , Calcium Signaling/physiology , Cardiomegaly/metabolism , Myocardium/metabolism , Protein Subunits , Action Potentials/drug effects , Action Potentials/physiology , Animals , Caffeine/pharmacology , Calcium/metabolism , Calcium Channels, L-Type/genetics , Calcium Signaling/drug effects , Calcium-Binding Proteins/metabolism , Calcium-Transporting ATPases/metabolism , Cardiac Pacing, Artificial , Cardiomegaly/genetics , Cell Separation , Cytosol/metabolism , Homeostasis , In Vitro Techniques , Mice , Mice, Transgenic , Myocardium/cytology , Patch-Clamp Techniques , Ryanodine Receptor Calcium Release Channel/metabolism , Sarcolemma/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases , Sodium-Calcium Exchanger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...